Therefore, we stratified our analysis by circulating C-peptide concentration to evaluate whether the association between IGF-1 and IGFBP-3, and pancreatic cancer was different in individuals with high or low C-peptide levels. The gene discussed is IGFBP3; the disease is familial pancreatic carcinoma.